AR also enhanced MYC transcriptional activity by phosphorylating MAD1 and promoting activation of the HER2/HER3 signaling pathway, leading to increased levels of MYC/MAX heterodimers that ultimately promoted breast cancer growth 15. The gene discussed is AR; the disease is breast carcinoma.